Accuray (ARAY) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
ARAY slides 8.4% to $0.16, a 52-week low, 9 down days in a row. Closed at $0.16, -8.41% vs the prior close of $0.17. Day range $0.15–$0.18, opened at $0.17.
ARAY daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ARAY slides 8.4% to $0.16, a 52-week low, 9 down days in a row
- Closed at $0.16, -8.41% vs the prior close of $0.17. Day range $0.15–$0.18, opened at $0.17.
- Volume was 1.94M shares, 0.2x its 50-day average of 8.82M — lighter than usual.
- Price is -39.2% vs its 50-day average ($0.26) and -61.6% vs its 200-day average ($0.41).
- 52-week range $0.15–$1.86; today's close sits at 0% of that range, 91.6% below the 52-week high.
- That makes 9 straight losses.
Oct 15, 2026 — ARAY slides 5.6% to $0.17, a 52-week low, 8 down days in a row
- Closed at $0.17, -5.56% vs the prior close of $0.18. Day range $0.16–$0.18, opened at $0.17.
- Volume was 2.48M shares, 0.3x its 50-day average of 8.79M — lighter than usual.
- Price is -34.2% vs its 50-day average ($0.26) and -58.4% vs its 200-day average ($0.41).
- 52-week range $0.16–$1.86; today's close sits at 1% of that range, 90.9% below the 52-week high.
- That makes 8 straight losses.
Oct 14, 2026 — ARAY slides 5.3% to $0.18, a 52-week low, 7 down days in a row
- Closed at $0.18, -5.26% vs the prior close of $0.19. Day range $0.18–$0.19, opened at $0.19.
- Volume was 1.37M shares, 0.2x its 50-day average of 8.80M — lighter than usual.
- Price is -30.9% vs its 50-day average ($0.26) and -56.3% vs its 200-day average ($0.41).
- 52-week range $0.18–$1.86; today's close sits at 0% of that range, 90.3% below the 52-week high.
- That makes 7 straight losses.
Oct 13, 2026 — ARAY slides 13.6% to $0.19, a 52-week low, 6 down days in a row
- Closed at $0.19, -13.64% vs the prior close of $0.22. Day range $0.19–$0.21, opened at $0.21.
- Volume was 3.28M shares, 0.4x its 50-day average of 8.74M — lighter than usual.
- Price is -27.8% vs its 50-day average ($0.26) and -54.2% vs its 200-day average ($0.42).
- 52-week range $0.19–$1.93; today's close sits at 0% of that range, 90.2% below the 52-week high.
- That makes 6 straight losses.
- SEC filings that day: 8-K.
Oct 12, 2026 — ARAY slides 4.3% to $0.22, 5 down days in a row
- Closed at $0.22, -4.35% vs the prior close of $0.23. Day range $0.21–$0.23, opened at $0.22.
- Volume was 851.10K shares, 0.1x its 50-day average of 8.77M — lighter than usual.
- Price is -16.9% vs its 50-day average ($0.26) and -47.4% vs its 200-day average ($0.42).
- 52-week range $0.21–$2.10; today's close sits at 1% of that range, 89.5% below the 52-week high.
- That makes 5 straight losses.
Oct 9, 2026 — ARAY slides 4.2% to $0.23, 4 down days in a row
- Closed at $0.23, -4.17% vs the prior close of $0.24. Day range $0.22–$0.24, opened at $0.24.
- Volume was 1.73M shares, 0.2x its 50-day average of 8.93M — lighter than usual.
- Price is -13.4% vs its 50-day average ($0.27) and -45.4% vs its 200-day average ($0.42).
- 52-week range $0.22–$2.10; today's close sits at 1% of that range, 89.0% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — ARAY slides 4.0% to $0.24, 3 down days in a row
- Closed at $0.24, -4.00% vs the prior close of $0.25. Day range $0.23–$0.25, opened at $0.25.
- Volume was 2.46M shares, 0.3x its 50-day average of 8.90M — lighter than usual.
- Price is -10.0% vs its 50-day average ($0.27) and -43.5% vs its 200-day average ($0.42).
- 52-week range $0.22–$2.10; today's close sits at 1% of that range, 88.6% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — ARAY slides 3.8% to $0.25
- Closed at $0.25, -3.85% vs the prior close of $0.26. Day range $0.24–$0.27, opened at $0.26.
- Volume was 1.97M shares, 0.2x its 50-day average of 8.91M — lighter than usual.
- Price is -6.2% vs its 50-day average ($0.27) and -41.6% vs its 200-day average ($0.43).
- 52-week range $0.22–$2.10; today's close sits at 2% of that range, 88.1% below the 52-week high.
Oct 6, 2026 — ARAY slides 13.3% to $0.26
- Closed at $0.26, -13.33% vs the prior close of $0.30. Day range $0.26–$0.32, opened at $0.30.
- Volume was 1.84M shares, 0.2x its 50-day average of 8.88M — lighter than usual.
- Price is -2.4% vs its 50-day average ($0.27) and -39.7% vs its 200-day average ($0.43).
- 52-week range $0.22–$2.10; today's close sits at 2% of that range, 87.6% below the 52-week high.
- SEC filings that day: 8-K.
Oct 5, 2026 — ARAY jumps 7.1% to $0.30
- Closed at $0.30, +7.14% vs the prior close of $0.28. Day range $0.27–$0.32, opened at $0.28.
- Volume was 2.21M shares, 0.2x its 50-day average of 8.86M — lighter than usual.
- Price is +12.9% vs its 50-day average ($0.27) and -31.0% vs its 200-day average ($0.43).
- 52-week range $0.22–$2.10; today's close sits at 4% of that range, 85.7% below the 52-week high.
Oct 2, 2026 — ARAY jumps 3.7% to $0.28
- Closed at $0.28, +3.70% vs the prior close of $0.27. Day range $0.26–$0.30, opened at $0.26.
- Volume was 4.68M shares, 0.5x its 50-day average of 8.79M — lighter than usual.
- Price is +5.8% vs its 50-day average ($0.26) and -36.1% vs its 200-day average ($0.44).
- 52-week range $0.22–$2.10; today's close sits at 3% of that range, 86.7% below the 52-week high.
ARAY latest news & SEC filings
Every SEC filing by or about ARAY in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Oct 16, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 7, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
- Item 8.01 — Reported other events the company considers important.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Pervaiz Ali received an award of 19,811 shares on Sep 23, 2026; now holds 375,174
- Pervaiz Ali had withheld for taxes 8,915 shares at $0.23 (≈$2.01K) on Sep 23, 2026; now holds 366,259
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 11, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Sep 11, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 2, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 27, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Revenue: $401.95M (prior year $458.50M) (-12.3% vs Jun 30, 2025)
- Net income: -$49.19M (prior year -$1.59M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.40 (prior year -$0.02) (loss widened vs Jun 30, 2025)
Aug 24, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Things to know before you trade ARAY
- Last results release: Aug 19, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 4, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 18, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 6.63% (largest 36.4%). That is a volatile stock.
- Liquidity: about 21.25M shares (≈$3.31M) trade per day on average.
- 52-week position: $0.16 vs a range of $0.15–$1.86 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 16 open-market buys, 0 sales; latest: Steven F Mayer bought 54,875 shares on Feb 20, 2026.
- Latest filings: 8-K Oct 13, 2026; 8-K Oct 6, 2026; 10-K Aug 27, 2026.
- Share count: 119.44M shares outstanding (Aug 21, 2026), +6.0% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
ARAY market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.17 | 0.18 | 0.15 | 0.16 | 1.94M |
| Oct 15, 2026 | 0.17 | 0.18 | 0.16 | 0.17 | 2.48M |
| Oct 14, 2026 | 0.19 | 0.19 | 0.18 | 0.18 | 1.37M |
| Oct 13, 2026 | 0.21 | 0.21 | 0.19 | 0.19 | 3.28M |
| Oct 12, 2026 | 0.22 | 0.23 | 0.21 | 0.22 | 851.10K |
| Oct 9, 2026 | 0.24 | 0.24 | 0.22 | 0.23 | 1.73M |
| Oct 8, 2026 | 0.25 | 0.25 | 0.23 | 0.24 | 2.46M |
| Oct 7, 2026 | 0.26 | 0.27 | 0.24 | 0.25 | 1.97M |
| Oct 6, 2026 | 0.30 | 0.32 | 0.26 | 0.26 | 1.84M |
| Oct 5, 2026 | 0.28 | 0.32 | 0.27 | 0.30 | 2.21M |
| Oct 2, 2026 | 0.26 | 0.30 | 0.26 | 0.28 | 4.68M |
| Oct 1, 2026 | 0.25 | 0.29 | 0.25 | 0.27 | 2.67M |
| Sep 30, 2026 | 0.28 | 0.29 | 0.27 | 0.27 | 4.05M |
| Sep 29, 2026 | 0.26 | 0.30 | 0.25 | 0.30 | 12.88M |
| Sep 28, 2026 | 0.29 | 0.38 | 0.28 | 0.30 | 377.45M |
| Sep 25, 2026 | 0.23 | 0.23 | 0.22 | 0.22 | 760.30K |
| Sep 24, 2026 | 0.22 | 0.23 | 0.22 | 0.22 | 911.70K |
| Sep 23, 2026 | 0.24 | 0.24 | 0.23 | 0.23 | 389.30K |
| Sep 22, 2026 | 0.24 | 0.25 | 0.23 | 0.23 | 471.10K |
| Sep 21, 2026 | 0.23 | 0.25 | 0.23 | 0.24 | 534.90K |
About Accuray
Accuray (ARAY) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in MADISON, WI. State of incorporation: DE. Fiscal year ends June 30. SEC CIK 1138723.
ARAY board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Chan Galbato | Director | Dec 2, 2025 |
| Beverly A Huss | Director | Dec 2, 2025 |
| James M. Hindman | Director | Dec 2, 2025 |
| Robert Kill | Director | Nov 17, 2025 |
| Neve Stephen R. La | CEO | Dec 2, 2025 |
| Grand Anne Bryce Le | Director | Dec 2, 2025 |
| Steven F Mayer | Director | Feb 23, 2026 |
| Mika Nishimura | Director | Dec 2, 2025 |
| Byron C Scott | Director | Jan 9, 2026 |
| Joseph E Whitters | Director | Dec 2, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Sandeep Chalke | SVP, Chief Commercial Officer | Apr 1, 2026 |
| Neve Stephen R. La | CEO | Dec 2, 2025 |
| Michael John Murphy | VP, Corporate Controller | Nov 3, 2025 |
| Paul Michael Miele | SVP, Chief Commercial Officer | May 29, 2026 |
| Leonel Peralta | SVP, Chief Operations Officer | Mar 3, 2026 |
| Ali Pervaiz | SVP Chief Financial Officer | Dec 2, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Feb 20, 2026 | Steven F Mayer | Buy | 54,875 | $0.56 |
| Feb 20, 2026 | Steven F Mayer | Buy | 54,875 | $0.56 |
| Feb 20, 2026 | Steven F Mayer | Buy | 54,875 | $0.56 |
| Feb 20, 2026 | Steven F Mayer | Buy | 54,875 | $0.56 |
| Feb 19, 2026 | Steven F Mayer | Buy | 69,000 | $0.53 |
| Feb 19, 2026 | Steven F Mayer | Buy | 69,000 | $0.53 |
| Feb 19, 2026 | Steven F Mayer | Buy | 69,000 | $0.53 |
| Feb 19, 2026 | Steven F Mayer | Buy | 69,000 | $0.53 |
| Feb 18, 2026 | Steven F Mayer | Buy | 126,125 | $0.53 |
| Feb 18, 2026 | Steven F Mayer | Buy | 126,125 | $0.53 |
| Feb 18, 2026 | Steven F Mayer | Buy | 126,125 | $0.53 |
| Feb 18, 2026 | Steven F Mayer | Buy | 126,125 | $0.53 |
| Nov 19, 2025 | Neve Stephen R. La | Buy | 20,000 | $0.97 |
| Nov 19, 2025 | Neve Stephen R. La | Buy | 20,000 | $0.97 |
| Nov 19, 2025 | Neve Stephen R. La | Buy | 20,000 | $0.97 |
ARAY financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | $401.95M | $-49.19M | — | $-6.98M |
| Jun 30, 2025 | $458.50M | $-1.59M | -0.02 | $2.86M |
| Jun 30, 2024 | $446.55M | $-15.54M | -0.16 | $-11.90M |
| Jun 30, 2023 | $447.61M | $-9.28M | -0.10 | $15.54M |
| Jun 30, 2022 | $429.91M | $-5.35M | -0.06 | $-2.40M |
Latest balance sheet: total assets $443.68M, total liabilities $401.98M, cash $40.62M (as of Jun 30, 2026).
ARAY earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 19, 2026 | 8-K Item 2.02 (results) | $0.29 |
| May 6, 2026 | 8-K Item 2.02 (results) | $0.48 |
| Feb 4, 2026 | 8-K Item 2.02 (results) | $0.76 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $1.45 |
| Oct 20, 2025 | 8-K Item 2.02 (results) | $1.69 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $1.49 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $1.55 |
| Feb 5, 2025 | 8-K Item 2.02 (results) | $2.49 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $2.03 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
| Jan 31, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ARAY
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.